European antitrust

Pfizer, Inc.’s acquisition of Ferrosan Holding’s consumer health care business will not significantly lessen competition in the European Economic Area, the EC announced on June 10....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at